335 related articles for article (PubMed ID: 33268763)
41. Donor-derived human herpesvirus 8 infection with Kaposi sarcoma and Kaposi sarcoma inflammatory cytokine syndrome in a heart transplant recipient: A case report.
Antonio R; Laura G; Nicolina C; Elena S; Luca V; Tiziana L; Luciano P; Davide P; Nazzareno G
Transpl Infect Dis; 2021 Aug; 23(4):e13609. PubMed ID: 33768668
[TBL] [Abstract][Full Text] [Related]
42. A variant of KSHV-associated inflammatory cytokine syndrome in elderly men of Mediterranean descent.
Liapis K; Bouzani M; Petrakis V; Anagnostopoulos NI; Kotsianidis I
Infection; 2024 Jun; 52(3):1175-1180. PubMed ID: 38113021
[TBL] [Abstract][Full Text] [Related]
43. A novel approach for characterization of KSHV-associated multicentric Castleman disease from effusions.
Zhou T; Yuan CM; Lurain K; Rous C; Weaver L; Raffeld M; Stetler-Stevenson M; Uldrick TS; Filie AC; Pittaluga S; Jaffe ES; Marshall V; Moore K; Whitby D; Ramaswami R; Yarchoan R; Wang HW
Br J Haematol; 2023 Feb; 200(4):462-475. PubMed ID: 36264007
[TBL] [Abstract][Full Text] [Related]
44. Immunophenotypic analysis of the Kaposi sarcoma herpesvirus (KSHV; HHV-8)-infected B cells in HIV+ multicentric Castleman disease (MCD).
Chadburn A; Hyjek EM; Tam W; Liu Y; Rengifo T; Cesarman E; Knowles DM
Histopathology; 2008 Nov; 53(5):513-24. PubMed ID: 18983461
[TBL] [Abstract][Full Text] [Related]
45. Kaposi sarcoma-associated herpesvirus (KSHV): molecular biology and oncogenesis.
Wen KW; Damania B
Cancer Lett; 2010 Mar; 289(2):140-50. PubMed ID: 19651473
[TBL] [Abstract][Full Text] [Related]
46. Human immunodeficiency virus-associated Kaposi sarcoma as an immune reconstitution inflammatory syndrome: a literature review and case report.
Feller L; Anagnostopoulos C; Wood NH; Bouckaert M; Raubenheimer EJ; Lemmer J
J Periodontol; 2008 Feb; 79(2):362-8. PubMed ID: 18251652
[TBL] [Abstract][Full Text] [Related]
47. Multicentric Castleman disease: Where are we now?
Wang HW; Pittaluga S; Jaffe ES
Semin Diagn Pathol; 2016 Sep; 33(5):294-306. PubMed ID: 27296355
[TBL] [Abstract][Full Text] [Related]
48. A fatal case of kaposi sarcoma due to immune reconstitution inflammatory syndrome.
Stover KR; Molitorisz S; Swiatlo E; Muzny CA
Am J Med Sci; 2012 May; 343(5):421-5. PubMed ID: 22227511
[TBL] [Abstract][Full Text] [Related]
49. Rapidly Disseminated Kaposi's Sarcoma Despite Initiation of Antiretroviral Therapy.
Saberian C; Campbell BR
Cureus; 2023 May; 15(5):e39627. PubMed ID: 37256167
[TBL] [Abstract][Full Text] [Related]
50. Impact of valganciclovir therapy on severe IRIS-Kaposi Sarcoma mortality: An open-label, parallel, randomized controlled trial.
Volkow P; Chavez Galan L; Ramon-Luing L; Cruz-Velazquez J; Cornejo-Juarez P; Sada-Ovalle I; Perez-Padilla R; Islas-Muñoz B;
PLoS One; 2023; 18(5):e0280209. PubMed ID: 37195970
[TBL] [Abstract][Full Text] [Related]
51. Epstein-barr virus- and Kaposi sarcoma-associated herpesvirus-related malignancies in the setting of human immunodeficiency virus infection.
Pinzone MR; Berretta M; Cacopardo B; Nunnari G
Semin Oncol; 2015 Apr; 42(2):258-71. PubMed ID: 25843730
[TBL] [Abstract][Full Text] [Related]
52. Rituximab plus liposomal doxorubicin in HIV-infected patients with KSHV-associated multicentric Castleman disease.
Uldrick TS; Polizzotto MN; Aleman K; Wyvill KM; Marshall V; Whitby D; Wang V; Pittaluga S; O'Mahony D; Steinberg SM; Little RF; Yarchoan R
Blood; 2014 Dec; 124(24):3544-52. PubMed ID: 25331113
[TBL] [Abstract][Full Text] [Related]
53. Successful treatment of an HIV-positive patient with unmasking Kaposi's sarcoma immune reconstitution inflammatory syndrome.
Speicher DJ; Sehu MM; Johnson NW; Shaw DR
J Clin Virol; 2013 Jul; 57(3):282-5. PubMed ID: 23578530
[TBL] [Abstract][Full Text] [Related]
54. Disseminated Kaposi sarcoma with cytokine release in an AIDS patient.
Chang KM; Hsieh SL; Harris CA
J Microbiol Immunol Infect; 2022 Apr; 55(2):344-346. PubMed ID: 33893052
[No Abstract] [Full Text] [Related]
55. Kaposi Sarcoma Inflammatory Cytokine Syndrome (KICS): A Rare but Potentially Treatable Condition.
Karass M; Grossniklaus E; Seoud T; Jain S; Goldstein DA
Oncologist; 2017 May; 22(5):623-625. PubMed ID: 28424322
[TBL] [Abstract][Full Text] [Related]
56. Does Kaposi's sarcoma predict multicentric Castleman disease in the presence of generalized lymphadenopathy?
Alkaied H; Harris K; Elsayegh D; Khachaturova I; Awasum M; Varma S
Med Oncol; 2012 Jun; 29(2):1109-13. PubMed ID: 21472488
[TBL] [Abstract][Full Text] [Related]
57. HIV-associated multicentric Castleman disease: a report of 19 cases at an oncology institution.
Volkow-Fernández P; Lome-Maldonado C; Quintero-Buenrostro H; Islas-Muñoz B; Cornejo-Juárez P
Int J STD AIDS; 2020 Mar; 31(4):318-325. PubMed ID: 32089093
[No Abstract] [Full Text] [Related]
58. Kaposi sarcoma-associated herpesvirus (human herpesvirus type 8)-associated extracavitary lymphoma: Report of a case in an HIV-positive patient with simultaneous kaposi sarcoma and a review of the literature.
Zhang H; Yang XY; Hong T; Feldman T; Bhattacharyya PK
Acta Haematol; 2010; 123(4):237-41. PubMed ID: 20484888
[TBL] [Abstract][Full Text] [Related]
59. Can plasma HHV8 viral load be used to differentiate multicentric Castleman disease from Kaposi sarcoma?
Sayer R; Paul J; Tuke PW; Hargreaves S; Noursadeghi M; Tedder RS; Grant P; Edwards SG; Miller RF
Int J STD AIDS; 2011 Oct; 22(10):585-9. PubMed ID: 21998180
[TBL] [Abstract][Full Text] [Related]
60. HIV-associated Kaposi sarcoma and related diseases.
Gonçalves PH; Uldrick TS; Yarchoan R
AIDS; 2017 Sep; 31(14):1903-1916. PubMed ID: 28609402
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
